Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Toxemia D014115 3 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thrombosis D013927 49 associated lipids
Thrombocytosis D013922 4 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombasthenia D013915 4 associated lipids
Thalassemia D013789 8 associated lipids
Tangier Disease D013631 8 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Stomatitis D013280 14 associated lipids
Stomach Ulcer D013276 75 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Spasm D013035 5 associated lipids
Sneezing D012912 6 associated lipids
Shock, Traumatic D012774 4 associated lipids
Shock, Septic D012772 11 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Freitag A et al. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. 1993 Thorax pmid:8346486
Villa L et al. Chiral PAF agonists: synthesis, theoretical analysis of their stereoelectronic properties and structure activity relationships. 1993 Farmaco pmid:8343209
Hofer RE et al. The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia. 1993 Anesthesiology pmid:8342844
Gulbins E et al. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. 1993 Am. J. Physiol. pmid:8342619
Read RA et al. Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion. 1993 Surgery pmid:8342134
Bozza PT et al. Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat; a role for a newly generated protein. 1993 Eur. J. Pharmacol. pmid:8339753
Kawamura M et al. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation. 1993 Thromb. Res. pmid:8332959
Onuki Y et al. [Experimental studies on the relation of platelet activating factor (PAF) to high mortality in sublethal endotoxemia after massive hepatectomy and effects of its antagonist]. 1993 Nihon Geka Gakkai Zasshi pmid:8332121
Kohler C et al. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses. 1993 Inflammation pmid:8330926
Barr RM et al. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment. 1993 Br J Clin Pharmacol pmid:8329291
Tanaka T et al. Effect of a novel xanthine derivative on experimental ulcers in rats. 1993 Arzneimittelforschung pmid:8329000
Patterson WR et al. Aggregation of killer whale platelets. 1993 Thromb. Res. pmid:8327987
Ohashi M et al. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis. 1993 Int. Arch. Allergy Immunol. pmid:8324390
Amorim CZ et al. Interference of PCA 4248, a novel PAF receptor antagonist, with antigen-induced paw edema in mice. 1993 Eur. J. Pharmacol. pmid:8319756
Chiche D et al. Pulmonary edema and shock after high-dose aracytine-C for lymphoma; possible role of TNF-alpha and PAF. 1993 Mar-Apr Eur. Cytokine Netw. pmid:8318674
Ohar JA et al. Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs. 1993 Am. Rev. Respir. Dis. pmid:8317792
Boonen GJ et al. Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. 1993 Agents Actions pmid:8317308
Kantar A et al. Effect of PAF on human lymphocyte membranes: a fluorescence study. 1993 Agents Actions pmid:8317302
Silliman CC et al. Compounds biologically similar to platelet activating factor are present in stored blood components. 1993 Lipids pmid:8316049
Matsumoto K et al. [Platelet activating factor and tumor necrosis factor-alpha in bronchoalveolar lavage fluid of patients with ARDS]. 1993 Nihon Kyobu Shikkan Gakkai Zasshi pmid:8315901
Senoh M et al. Early release of neutrophil chemotactic factor from isolated rat heart subjected to regional ischaemia followed by reperfusion. 1993 Cardiovasc. Res. pmid:8313428
Ripps BA et al. Platelet-activating factor production from in vitro and in vivo fertilized murine embryos is similar. 1993 Sep-Oct Am. J. Reprod. Immunol. pmid:8311917
Katoh N et al. [Evaluation of the mechanism of endothelin-induced rat gastric mucosal lesion formation]. 1994 Nihon Shokakibyo Gakkai Zasshi pmid:8309086
Okawa T et al. [Endothelin-1-induced contraction of pregnant rat myometrium: role of platelet-activating factor]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8308402
Stoll LL et al. Platelet-activating factor may stimulate both receptor-dependent and receptor-independent increases in [Ca2+] in human airway epithelial cells. 1994 J. Biol. Chem. pmid:8307989
Stroman PW et al. Evaluation of effects of PAF on alveolar fluid clearance with use of NMR imaging. 1993 J. Appl. Physiol. pmid:8307842
Denizot Y and Chaussade S Tumor necrosis factor and platelet activating factor in stool during salmonellosis. 1994 Gut pmid:8307492
Sun X et al. Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor. 1994 Gut pmid:8307472
Denizot Y and Chaussade S Platelet activating factor and Crohn's disease. 1994 Gut pmid:8307440
Graham RM et al. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. 1994 Crit. Care Med. pmid:8306677
Yamanaka S et al. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. 1993 Br. J. Pharmacol. pmid:8306093
Filep JG and Földes-Filep E Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. 1993 Br. J. Pharmacol. pmid:8306074
Thorne JR and Broadley KJ Adenosine-induced bronchoconstriction in conscious hyperresponsive and sensitized guinea pigs. 1994 Am. J. Respir. Crit. Care Med. pmid:8306036
Nishihira J et al. A role for oxygen radicals in rat monocytic leukemia cell differentiation under stimulation with platelet-activating factor. 1994 Biochim. Biophys. Acta pmid:8305501
Jambou D et al. [Mediators of the vascular endothelium as markers of myocardial ischemia and reperfusion]. 1993 Arch Mal Coeur Vaiss pmid:8304814
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Northover AM and Northover BJ Involvement of protein kinase C in the control of microvascular permeability to colloidal carbon. 1993 Agents Actions pmid:8304240
Kosar-Hashemi B et al. Glyceryl ether monooxygenase [EC 1.14.16.5]: stoichiometry and inhibition. 1993 Adv. Exp. Med. Biol. pmid:8304231
Saeed SA et al. Rhazimine from Rhazya stricta: a dual inhibitor of arachidonic acid metabolism and platelet activating factor-induced platelet aggregation. 1993 Planta Med. pmid:8302958
David S et al. Adherence of human monocytes to haemodialysis membranes. 1993 Nephrol. Dial. Transplant. pmid:8302460
Caplan MS et al. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. 1994 Gastroenterology pmid:8299901
Sjogren R et al. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. 1994 Gastroenterology pmid:8299898
Shinozaki K et al. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood. 1994 Life Sci. pmid:8295490
Hodgkin EE et al. A Monte Carlo pharmacophore generation procedure: application to the human PAF receptor. 1993 J. Comput. Aided Mol. Des. pmid:8294944
Honda Z et al. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. 1994 J. Biol. Chem. pmid:8294489
Bell M et al. Effect of cryoprotective additives and cryopreservation protocol on sperm membrane lipid peroxidation and recovery of motile human sperm. 1993 Nov-Dec J. Androl. pmid:8294232
Pi F et al. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. 1994 Transplantation pmid:8291097
Chang SW Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor. 1994 J. Lab. Clin. Med. pmid:8288963
Sugatani J et al. Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation. 1993 J. Immunol. Methods pmid:8288878
Parks JE and Hough SR Platelet-activating factor acetylhydrolase activity in bovine seminal plasma. 1993 Sep-Oct J. Androl. pmid:8288488
Leoncini G et al. S-D-lactoylglutathione accumulation in activated human platelets. 1993 Int. J. Biochem. pmid:8288025
Chen BN et al. Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart. 1993 Cardiovasc. Res. pmid:8287433
Chupin VV et al. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine]. 1993 Bioorg. Khim. pmid:8285924
Gupta JB et al. Platelet-activating-factor-induced changes in cardiovascular function and oxyradical status of myocardium in presence of the PAF antagonist CV-6209. 1994 Angiology pmid:8285381
Zeng GQ et al. Effects of dauricine and tetrandrine on [3H] WEB 2086 specific binding to bovine anterior cerebral arterial smooth muscle cells in vitro. 1993 Yao Xue Xue Bao pmid:8285049
Gerard NP and Gerard C Receptor-dependent internalization of platelet-activating factor. 1994 J. Immunol. pmid:8283052
Tordai A et al. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine. 1994 J. Immunol. pmid:8283038
Rodriguez-Roisin R et al. Platelet-activating factor causes ventilation-perfusion mismatch in humans. 1994 J. Clin. Invest. pmid:8282786
Maziere C et al. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells. 1994 Biochim. Biophys. Acta pmid:8280775
O'Flaherty JT et al. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. 1994 Biochim. Biophys. Acta pmid:8280772
Tanaka T et al. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. 1994 Biochim. Biophys. Acta pmid:8280771
Parent JL and Stankova J Transforming growth factor-beta up-regulates the gene expression of the human platelet-activating factor receptor in monocytic and B cell lines. 1993 Biochem. Biophys. Res. Commun. pmid:8280163
Turner JS et al. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. 1994 Biochem. J. pmid:8280096
Thompson WA et al. The metabolic effects of platelet-activating factor antagonism in endotoxemic man. 1994 Arch Surg pmid:8279943
Huber W et al. Leukotriene B4 and C4 production in isolated rat gastric mucosal cells. 1993 Am. J. Physiol. pmid:8279553
Denizot Y et al. [Fecal platelet-activating factor (PAF). A marker of digestive inflammatory disorders]. 1993 Presse Med pmid:8278326
Zhou W et al. Lipid mediator production in acute and chronic pancreatitis in the rat. 1994 J. Surg. Res. pmid:8277767
DeJoy SQ et al. Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis. 1994 J. Infect. Dis. pmid:8277176
Montero A et al. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. 1993 Eur. J. Pharmacol. pmid:8276075
Chau LY and Hu CY Platelet-activating factor receptor-mediated calcium influx in NG 108-15 cells. 1993 Chin J Physiol pmid:8275798
Chen ZN [Recent progress in the study of anti-PAF (platelet activating factor) constituents of medicinal herbs]. 1993 Zhongguo Zhong Yao Za Zhi pmid:8274205
Glaser KB et al. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). 1993 Agents Actions pmid:8273577
Thomas TK et al. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. 1993 Agents Actions pmid:8273566
Meats JE et al. Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. 1993 Agents Actions pmid:8273553
Raff GW et al. Procoagulant property of platelet activating factor (PAF). 1993 Agents Actions pmid:8273543
Jørgensen L et al. Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy. 1993 Scand. J. Clin. Lab. Invest. pmid:8272758
Roberts C et al. Platelet activating factor (PAF) enhances mitosis in preimplantation mouse embryos. 1993 Reprod. Fertil. Dev. pmid:8272531
Hirashima Y et al. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. 1994 J. Neurosurg. pmid:8271019
Stephens CJ et al. Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. 1993 Coron. Artery Dis. pmid:8269210
David S et al. Production of platelet activating factor by human neutrophils after backfiltration of endotoxin contaminated dialysate. 1993 Jul-Sep ASAIO J. pmid:8268642
Okamoto Y et al. PAF-releasing factor in human serum and inflammatory exudate. 1993 J Lipid Mediat pmid:8268461
Vásquez-Bravo YL et al. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists. 1993 J Lipid Mediat pmid:8268459
Tjebbes GW et al. Production of lipid mediators in experimental keratitis of rabbit eye. 1993 J Lipid Mediat pmid:8268458
Manzini S et al. Interactions between sensory neuropeptides and lipid mediators in the airways. 1993 J Lipid Mediat pmid:8268456
Waga I et al. Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin. 1993 Biochem. Biophys. Res. Commun. pmid:8267581
Corcoran PC et al. Reduction of conjugated dienes in lung transplantation: effect of BN 52021. 1993 Ann. Thorac. Surg. pmid:8267425
Freire-Maia L and de Matos IM Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. 1993 Toxicon pmid:8266352
McManus LM et al. PAF molecular heterogeneity: pathobiological implications. 1993 Lab. Invest. pmid:8264227
Rabinovici R et al. Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. 1993 J. Pharmacol. Exp. Ther. pmid:8263817
Raeburn D and Karlsson JA Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. 1993 J. Pharmacol. Exp. Ther. pmid:8263775
Hartnell A et al. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. 1993 Immunology pmid:8262555
Elwood W et al. Role of cyclooxygenase and 5-lipoxygenase metabolites, platelet-activating factor and 5-hydroxytryptamine in allergen-induced airway responses in the brown Norway rat. 1994 Int. Arch. Allergy Immunol. pmid:8260852
MacKendrick W et al. Increase in plasma platelet-activating factor levels in enterally fed preterm infants. 1993 Biol. Neonate pmid:8260551
Steen VM et al. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. 1993 Thromb. Haemost. pmid:8259557
Doly M et al. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730. 1993 Ophthalmic Res. pmid:8259265
Noris M et al. Defective glomerular [3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis. 1993 Kidney Int. pmid:8258952
Squadrito F et al. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury. 1993 J Lipid Mediat pmid:8257777
Herbert JM et al. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. 1993 J Lipid Mediat pmid:8257776
Chopra K et al. Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonist) to limit myocardial infarct size. 1993 Methods Find Exp Clin Pharmacol pmid:8255122
Palmblad J et al. Signal transduction mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils. 1994 J. Immunol. pmid:8254196